Pfizer (South Korea)

Recent papers from Pfizer (South Korea)

1. Real-world safety outcomes of COVID-19 mRNA vaccine: A result from Korea post-marketing surveillanceHuman Vaccines & Immunotherapeutics · 2026
2. Characterizing migraine burden and treatment response using nationwide smartphone app-based data in KoreaThe Journal of Headache and Pain · 2026
3. Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (−) metastatic breast cancer patients in Korea (KCSG BR21-15)The Breast · 2025
4. Somatrogon in pediatric growth hormone deficiency: a comprehensive review of clinical trials and real-world considerationsAnnals of Pediatric Endocrinology & Metabolism · 2025
5. Pneumococcal disease burden in high-risk older adults: Exploring impact of comorbidities, long-term care facilities, antibiotic resistance, and immunization policies through a narrative literature reviewHuman Vaccines & Immunotherapeutics · 2024
6. Risk Factors Associated With Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis in a Real‐World Setting in JapanInternational Journal of Rheumatic Diseases · 2024
7. Safety and effectiveness of tofacitinib in Korean adult patients with ulcerative colitis: post-marketing surveillance studyBMC Gastroenterology · 2024
8. Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic DermatitisJAMA Network Open · 2024
9. Cost-effectiveness analysis of the 20-valent pneumococcal conjugate vaccine for the pediatric population in South KoreaVaccine · 2024
10. Ab1723 Population-Based Big Data Analysis on Disease Patterns in Patients Identified With Juvenile Idiopathic Arthritis Using National Claims Data in South KoreaAnnals of the Rheumatic Diseases · 2024
11. Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational studyLara D. Veeken · 2024
12. Treatment Patterns and Persistence Among Patients Newly Diagnosed With Migraine in South Korea: A Retrospective Analysis of Health Claims DataJournal of Clinical Neurology · 2024
13. An Investigation in the Comparability of the Exposure and Recommended Dose of Selected Pfizer Drugs in East Asian Countries: Is Mutual Usage of Clinical Data Among East Asian Countries Feasible?The Journal of Clinical Pharmacology · 2023
14. Disease burden of bacteraemia with extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in KoreaJournal of Hospital Infection · 2023
15. Heterogeneous distributions in clinical events preceding anticoagulant treatment nonpersistence in patients with venous thromboembolism stratified by active cancer: A nationwide cohort studyCancer Medicine · 2023
16. Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancerGenome Medicine · 2023
17. Dynamic Patterns and Persistence of Anticoagulation Therapy in Patients with Venous Thromboembolism in South Korea: A Nationwide Cohort StudyThrombosis and Haemostasis · 2023
18. Longitudinal trajectories of sedation level and clinical outcomes in patients who are mechanically ventilated based on a group-based trajectory model: a prospective, multicentre, longitudinal and observational study in KoreaBMJ Open · 2023
19. Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective studyScientific Reports · 2023
20. Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumabArthritis Research & Therapy · 2023